|
|
Volumn 10, Issue 1, 2001, Pages 157-162
|
|
IBC's 11th Annual International Symposium: Advances in anticoagulant, antithrombotic and thrombolytic drugs
a
|
|
Author keywords
Anticoagulants; Antiplatelets; Antithrombotics; Low molecular weight heparin
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ARGATROBAN;
BLOOD CLOTTING FACTOR 10A;
CLOPIDOGREL;
DALTEPARIN;
ENOXAPARIN;
EPTIFIBATIDE;
FIBRINOGEN;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
FONDAPARINUX;
HEPARIN;
INTEGRIN;
LEFRADAFIBAN;
LOTRAFIBAN;
LOW MOLECULAR WEIGHT HEPARIN;
MELAGATRAN;
ORBOFIBAN;
PENTASACCHARIDE;
PROTEINASE;
SIBRAFIBAN;
TENECTEPLASE;
THROMBIN INHIBITOR;
TINZAPARIN;
TIROFIBAN;
UNINDEXED DRUG;
XEMILOFIBAN;
ANTICOAGULANT THERAPY;
ANTICOAGULATION;
ARTICLE;
BIOTECHNOLOGY;
BLEEDING;
BLOOD CLOTTING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG INDUSTRY;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SAFETY;
FIBRINOLYSIS;
FIBRINOLYTIC THERAPY;
HUMAN;
MAJOR CLINICAL STUDY;
MEDICAL SOCIETY;
ORGANIZATION;
RANDOMIZED CONTROLLED TRIAL;
SYMPOSIUM;
THROMBOCYTOPENIA;
THROMBOGENESIS;
THROMBOSIS;
VASCULAR DISEASE;
|
|
EID: 0035186071
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.10.1.157 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
